Experts Available to Discuss New USPSTF Prostate Cancer Screening Guidelines
American Society for Radiation Oncology (ASTRO)
Daily aspirin significantly increases the risk of melanoma for men Results surprising because aspirin is often reported to decrease risk of certain cancers Men who take daily aspirin may benefit from periodic skin exams by the dermatologist ‘This does not mean men should stop aspirin therapy’
To improve the impact of outreach efforts, researchers develop a better way to identify areas with high risk patients
It's important for everyone to perform regular skin self-exams to detect skin cancer early, when it's most treatable.
.
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore have found the role of the iron storage gene, FTH1, and its pseudogenes in regulating iron levels in cells and slowing down prostate cancer growth.
Many soldiers returning from combat bear visible scars, or even lost limbs, caused by blasts from improvised explosive devices, or IEDs. However, some servicemen also return with debilitating hidden injuries -- the loss of all or part of their genitals. Now, the Johns Hopkins reconstructive surgery team that performed the country's first bilateral arm transplant in a wounded warrior has successfully performed the first total penis and scrotum transplant in the world.
The Latest News On Marijuana Research
New research finds that more men have suboptimal testosterone levels than previously known, and it may be putting these men at risk.
A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system’s ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN. The study was led by investigators at The University of Texas MD Anderson Cancer Center.
Testicular cancer is the most common form of cancer in men ages 15 to 35. The American Cancer Society (ACS) estimates that there will be approximately 9,310 new cases of testicular cancer diagnosed in the United States in 2018.Testicular cancer grows in the tissues of one or both testes—glands that are located in the scrotum. Most cases of testicular cancer start out in the sperm-making cells known as germ cells. Testicular cancer can be classified into seminoma and nonseminoma. Although aggressive, both cancer types are curable even when metastatic.
Using chemotherapy along with aptamers -- lab-made molecules that function like antibodies -- Duke Health researchers showed that they can zero in on and kill prostate cancer tumors in mice while leaving healthy tissue unscathed.
UNC School of Medicine scientists led by Nikolay Dokholyan add to evidence that small aggregates of SOD1 protein are the brain-cell killing culprits in ALS, but the formation of larger, more visible, and fibril-like aggregates of the same protein may protect brain cells.
When prostate cancer metastasizes to bone, it can become especially dangerous – CU Cancer Center study at AACR18 hints at why: Cells involved in these bone metastases may release signals that drive the progression of the disease.
Newly expanded, the Program for Abdominal and Pelvic Health at Rush brings together a team of experts to address the complexity of pelvic health conditions and treat men and women suffering from them.
Conflict, a death in the family, financial hardship and serious medical crises are all associated with accelerated physical aging. In a new study, researchers at the University of California San Diego School of Medicine found that such negative fateful life events — or FLEs — appear to also specifically accelerate aging in the brain.
Men on hormone therapy for prostate cancer may benefit significantly from hitting the gym with fellow patients and choosing more veggies and fewer cheeseburgers, a new study suggests.
The Fred Hutch Tip Sheet includes story ideas about: New paths to malaria prevention; proteins involved in muscular dystrophy; pathogen-associated cancers; lung cancer in women who never smoked; financial impact of cancer care; more
By taking a high-cost drug with a low-fat meal—instead of on an empty stomach, as prescribed—prostate cancer patients could decrease their daily dose, prevent digestive issues and cut costs by 75 percent.
Gary Shapiro, President and CEO of the Consumer Technology Association (CTA)™, which annually produces CES®, the largest technology and innovation show in the world, will deliver a keynote address at the 6th International Symposium on Focused Ultrasound on Tuesday, October 23, 2018, in Reston, Virginia.
Click here to go directly to Newswise's Obesity News Source
New research presented at ENDO 2018 links semen count to other health problems
A new birth control pill for men appears to be safe when used daily for a month, with hormone responses consistent with effective contraception, study researchers say. Their study results, in 83 men, will be presented Sunday at ENDO 2018, the Endocrine Society’s 100th annual meeting in Chicago, Ill.
Chemicals found in a variety of routinely used consumer products may be contributing to the substantial drop in sperm counts and sperm quality among men in recent decades, a new study in mice suggests.
New scientific evidence has strengthened the case for reserving testosterone therapy for well-documented cases of hypogonadism, a condition where the body does not produce enough testosterone, Endocrine Society experts concluded in an updated Clinical Practice Guideline released today.
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology groups across North America, was led by researchers at Washington University School of Medicine in St. Louis.
On the forefront of innovative stroke treatment, Hackensack Meridian Health Hackensack University Medical Center provides leading edge thrombectomy technologies, amid new guidelines from the American Heart Association (AHA).
Requests for the procedure rise in March — when many men schedule downtime to watch basketball. A Michigan Medicine expert explains key facts.
In a collaborative, multi-institutional study published by JAMA Oncology, researchers from the University of Alabama at Birmingham, University of Chicago, and National Cancer Institute determined that MRI-based prediction models can help reduce unnecessary biopsies in suspected prostate cancer patients and help improve personalized risk stratification.
UCLA RESEARCH ALERT
To address embarrassing, inconvenient and costly male fertility testing, researchers from FAU are developing a home-based kit that accurately, quantitatively, and quickly, provides a complete semen evaluation using microfluidics, an app and a smartphone. After all, if women can use pregnancy tests in the comfort and privacy of their own homes, men also should be able to test their semen at home without any hassles.
Myers has spent the last decade researching the prevalence, possible causes, management and treatment of chemo-brain.
There is no shortage of men’s razors and other shaving tools on the market, but do any of them offer the perfect shave? According to dermatologists from the American Academy of Dermatology, it’s less about which tools you use, and more about your shaving preparation and technique.
UCLA researchers Dr. Leonard Marks and Shyam Natarajan will lead a $3.1 million research project grant awarded by the National Institutes of Health to advance the adoption of a promising new technology to treat men with prostate cancer. By helping to increase the widespread use of the technique, known as MRI-guided focal laser ablation, the research has the potential to vastly improve treatment options and outcomes for patients with the disease.
Radiation therapy is a popular and effective treatment for many men with prostate cancer, and now a temporary gel offers greater protection for organs at risk during treatments.
Prostate tumors tend to be what scientists call “indolent” – so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, the disease is invariably fatal. In a set of papers out today in the journals Nature Genetics and Nature Communications, researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) shed new light on the genetic mechanisms that promote metastasis in the mouse model and also implicated the typical Western high-fat diet as a key environmental factor driving metastasis.
An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate cancer, a disease that kills more than 26,000 American men annually.
Cancer cells can be destroyed more effectively and selectively with a unique new reusable treatment, activated with a substance found in stinging nettles and ants - thanks to new research by the University of Warwick.
A team from Roswell Park Cancer Institute has discovered a unique population of normal stem cells that may enable prostate cancer relapse. These findings may point the way toward strategies for treating or preventing prostate cancer recurrence.
The new COL (Ret.) David G. McLeod Prostate Cancer Translational Research Fellowship was awarded to Dr. Prachi Mishra, Dec. 7 at the Uniformed Services University of the Health Sciences (USU), in a ceremony in front of Department of Defense and industry leaders, cancer scientists, military healthcare providers and other colleagues.
Men infected with HPV16, the type responsible for most HPV-related cancers, are 20 times more likely to be reinfected with the same type of HPV after one year. That is according to a new study published this month in the Proceedings of the National Academy of Sciences. The article shows the same effect in both men who are sexually active and celibate, suggesting that they are not reacquiring the virus from another sexual partner.
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative to tumor tissue sequencing, and it is intended to specifically detect and sequence tumor DNA circulating in patients’ blood. The results are used to help guide doctors to tailor the best treatment for patients at each point of their disease.
A new study from Keck Medicine of USC finds that data from a novel recorder can be used to objectively measure surgeons’ proficiency in robotic-assisted prostate cancer surgery.
Researchers are developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. The tool eventually will help patients with other cancers as well.
NIBIB-funded scientists have developed a new technique for 3D-printing patient-specific organ models – here the prostate gland -- using polymers that accurately model the prostate’s dimensions and physical properties, while also providing quantitative tactile feedback, or response to pressure, incisions, and suturing.
New research shows how losing a ubiquitous gene opens genetic floodgates that make prostate cancer deadly, a finding that could apply to many cancers.
Hackensack Meridian Health Bayshore Medical Center is proud to announce that it has expanded services to include targeted MRI ultrasound for prostate biopsy. The procedure utilizes both ultrasound and magnetic resonance imaging (MRI) to allow for better targeting within the prostate, enabling cancerous cells to be more easily detected.
To help empower women in low- and middle-income countries and improve their health, the U.S. Agency for International Development through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) awarded RTI International a $4.8 million cooperative agreement to develop a dual-purpose drug delivery device for both HIV and pregnancy prevention that can be successfully used in these settings.
The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.